Anika Therapeutics Inc (ANIK)

Cost of Revenue

$11.37M

Quarterly · Period ending: · USD

ANIK logo

ANIK Cost of Revenue

Latest reported$11.37M
ANIK Quarterly Cost of Revenue ($400.00K → $11.37M)
High-resolution chart · PNG

ANIK cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
11,366,000
10,615,000
11,436,000
12,233,000
13,856,000
11,487,000
-23,855,000
37,313,000
10,235,000
15,895,000
16,642,000
16,521,000
15,330,000
15,081,000
15,491,000
17,485,000
14,795,000
14,889,000
17,687,000
16,513,000
17,333,000
13,318,000
15,944,000
14,351,000
16,936,000
14,200,000
8,649,000
5,951,000
6,836,000
7,311,000
7,001,000
8,282,000
8,152,000
7,845,000
8,716,000
6,250,000
6,315,000
6,083,000
7,539,000
4,998,000
6,065,000
5,425,000
6,290,000
5,175,723
5,274,059
4,313,440
5,511,586
5,724,800
5,332,913
4,361,019
6,235,334
5,377,568
6,311,332
4,841,170
7,269,886
7,221,028
8,084,226
6,413,481
7,128,450
7,394,922
6,655,804
5,604,562
6,702,674
6,108,502
5,891,752
5,123,675
3,613,028
3,551,374
3,294,160
3,211,666
2,822,930
3,504,986
3,644,530
3,216,070
3,225,979
3,138,307
3,023,781
2,492,922
3,054,111
2,125,028
2,890,904
3,047,818
2,266,000
3,767,000
2,117,000
2,994,000
2,335,000
2,451,000
2,442,000
2,721,000
2,260,000
1,930,000
1,846,000
1,969,000
1,688,446
2,131,517
2,201,318
2,087,414
1,597,172
2,553,582
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.